Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma.

Liu, Xiao-Ping; Yin, Xiao-Hong; Meng, Xiang-Yu; Yan, Xin-Hui; Wang, Fan; He, Li

Liu, Xiao-Ping; Yin, Xiao-Hong; Meng, Xiang-Yu; Yan, Xin-Hui; Wang, Fan; He, Li.

Afiliação

Liu XP; Zhongnan Hospital of Wuhan University, Wuhan, China.
Yin XH; Zhongnan Hospital of Wuhan University, Wuhan, China.
Meng XY; Zhongnan Hospital of Wuhan University, Wuhan, China.
Yan XH; Department of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
Wang F; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
He L; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Front Oncol ; 8: 615, 2018.

Article em En | MEDLINE | ID: mdl-30671382

Palavras-chave

LASSO Cox proportional hazards regression model; multiple myeloma; prognostic signature; survival; weighted co-expression network analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google